Trials in Tampa, Florida
Here are the top 10 medical studies for breast cancer in Tampa, Florida
Popular Filters
Phase 3 Trials
Hormone Therapy
Chemotherapy + Hormone Therapy for Breast Cancer
Recruiting2 awardsPhase 3
Carbondale, Illinois
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Monoclonal Antibodies
Sacituzumab Govitecan for Breast Cancer
Recruiting2 awardsPhase 3
Saint Petersburg, Florida
This trial will compare a new drug (SG) to current treatments for metastatic breast cancer to see if it can improve life spans. Primary objective is to compare its effect on progression-free survival (PFS).
Hormone Therapy
ARV-471 for Breast Cancer
Recruiting2 awardsPhase 3
Tampa, Florida
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Antibody-Drug Conjugate
Sacituzumab Govitecan + Pembrolizumab for Triple-Negative Breast Cancer
Recruiting4 awardsPhase 3
Tampa, Florida
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Selective Estrogen Receptor Degrader (SERD)
Giredestrant + Everolimus for Advanced or Metastatic Breast Cancer
Recruiting2 awardsPhase 3
Spring Hill, Florida
This trial is testing if a combination of giredestrant and everolimus works better than other hormone treatments plus everolimus in patients with advanced breast cancer who have already tried other treatments. The drugs work by blocking estrogen receptors and a growth pathway in cancer cells. Everolimus has been shown to improve outcomes in breast cancer patients when combined with hormonal treatments.
Trials With No Placebo
Hormone Therapy
Chemotherapy + Hormone Therapy for Breast Cancer
Recruiting2 awardsPhase 3
Carbondale, Illinois
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Monoclonal Antibodies
Sacituzumab Govitecan for Breast Cancer
Recruiting2 awardsPhase 3
Saint Petersburg, Florida
This trial will compare a new drug (SG) to current treatments for metastatic breast cancer to see if it can improve life spans. Primary objective is to compare its effect on progression-free survival (PFS).
Hormone Therapy
ARV-471 for Breast Cancer
Recruiting2 awardsPhase 3
Tampa, Florida
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.